| Jo L Dowling, NP | |
|
140 Hospital Dr, Suite 215, Bennington, VT 05201-5009 | |
| (802) 442-4785 | |
| (802) 447-3459 |
| Full Name | Jo L Dowling |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 140 Hospital Dr, Bennington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184677429 | NPI | - | NPPES |
| 4000052 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1010019869 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jo L Dowling, NP 140 Hospital Dr, Suite 215, Bennington, VT 05201-5009 Ph: (802) 442-4785 | Jo L Dowling, NP 140 Hospital Dr, Suite 215, Bennington, VT 05201-5009 Ph: (802) 442-4785 |
News Archive
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced that it has completed a private placement of $3,000,000 in convertible subordinated secured promissory notes (the "Notes") with two investors.
A collaboration involving the Icahn School of Medicine at Mount Sinai, the German Heart Center Munich, AstraZeneca, and Karolinska Institutet in Sweden has demonstrated that more than 30 percent of heart disease risk stems from genetic factors, much more than was previously understood.
After endless debates and controversies on whether two studies that demonstrated how bird flu, also known as avian H5N1 influenza, or avian flu, should be published, one of them has appeared in the latest issue of the journal Nature in its entirety. The two studies aimed for publication in journals Nature and Science show how the bird flu virus could become transmissible from mammal-to-mammal; as humans are mammals, the same would apply to humans.
"Scientists are warning officials negotiating a global treaty on mercury that banning the deadly chemical completely would be dangerous for public health because of the chemical's use in vaccines," the Associated Press reports.
Repros Therapeutics Inc. today announced that the Company has received verbal confirmation from the Division of Metabolic and Endocrine Drug Products of the Food and Drug Agency that the Company may initiate its Investigational New Drug Application for the study of oral Androxal® in the treatment of hypogonadal men with Type II Diabetes (T2D) with a Phase IIa trial.
› Verified 4 days ago
Melissa Rowe, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 655 Main St, Bennington, VT 05201 Phone: 802-447-2343 Fax: 802-442-4636 | |
Mrs. Stacey K Whitten, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 325 North St, Bennington, VT 05201 Phone: 802-447-6913 | |
Aimee Bullettsmith, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 140 Hospital Dr, Suite 215, Bennington, VT 05201 Phone: 802-442-2997 Fax: 802-447-0635 | |
Stephanie Sauer, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-447-5025 | |
Mrs. Whitney P Mical, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 655 Main St, Suite 1, Bennington, VT 05201 Phone: 802-447-2343 Fax: 802-442-4636 | |
Rebecca Filson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Drive, Box 65, Bennington, VT 05201 Phone: 802-447-5023 |